Vanguard Personalized Indexing Management
CRL icon

Vanguard Personalized Indexing Management’s Charles River Laboratories CRL Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Buy
12,212
+625
+5% +$111K 0.02% 532
2026
Q1 		$2M Sell
11,587
-429
-4% -$79.5K 0.02% 598
2025
Q4 		$2.4M Buy
12,016
+465
+4% +$84.3K 0.02% 537
2025
Q3 		$1.81M Sell
11,551
-127
-1% -$20.2K 0.02% 622
2025
Q2 		$1.77M Buy
11,678
+1,921
+20% +$256K 0.02% 611
2025
Q1 		$1.47M Buy
9,757
+1,752
+22% +$294K 0.02% 610
2024
Q4 		$1.48M Buy
8,005
+442
+6% +$85.1K 0.02% 591
2024
Q3 		$1.49M Sell
7,563
-623
-8% -$129K 0.02% 580
2024
Q2 		$1.69M Buy
8,186
+628
+8% +$142K 0.03% 464
2024
Q1 		$2.05M Buy
7,558
+242
+3% +$57.8K 0.04% 389
2023
Q4 		$1.73M Buy
7,316
+1,080
+17% +$212K 0.04% 390
2023
Q3 		$1.22M Sell
6,236
-362
-5% -$74.3K 0.04% 471
2023
Q2 		$1.39M Buy
6,598
+114
+2% +$22.7K 0.04% 427
2023
Q1 		$1.31M Buy
6,484
+738
+13% +$167K 0.05% 414
2022
Q4 		$1.25M Buy
5,746
+194
+3% +$42.4K 0.05% 418
2022
Q3 		$1.09M Buy
5,552
+381
+7% +$82.2K 0.05% 438
2022
Q2 		$1.11M Sell
5,171
-23
-0.4% -$5.62K 0.05% 415
2022
Q1 		$1.48M Sell
5,194
-125
-2% -$38.5K 0.07% 276
2021
Q4 		$2M Sell
5,319
-731
-12% -$284K 0.12% 164
2021
Q3 		$2.5M Sell
6,050
-354
-6% -$147K 0.22% 83
2021
Q2 		$2.37M Buy
6,404
+1,966
+44% +$656K 0.25% 75
2021
Q1 		$1.29M Buy
+4,438
New +$1.23M 0.19% 107

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Personalized Indexing Management's CRL Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Charles River Laboratories (CRL) stake by 5.4% in Q2 2026, buying an estimated $111K and bringing the position to 12,212 shares worth $2.77M. The position accounts for 0.02% of the portfolio, ranked #532.

Vanguard Personalized Indexing Management first reported a position in CRL in Q1 2021 and has held it in 22 quarters since. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Vanguard Personalized Indexing Management held 12,212 shares of Charles River Laboratories worth $2.77M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 625 Charles River Laboratories shares in Q2 2026, an estimated $111K.
  • Charles River Laboratories made up 0.02% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #532 holding.
  • Vanguard Personalized Indexing Management first reported a position in Charles River Laboratories in Q1 2021 and has held it in 22 quarters since.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.